The ACUTE trial. Transesophageal echocardiography to guide electrical cardioversion in atrial fibrillation. Assessment of Cardioversion Using Transesophageal Echocardiography.
The Assessment of Cardioversion Using Transesophageal Echocardiography (ACUTE) trial compared cardioversion following transesophageal echocardiography (TEE) against conventional management of atrial fibrillation (ie, cardioversion following 3 weeks of anticoagulation) in patients scheduled to undergo electrical cardioversion.
Asher
Craig R
CR
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, OH 44195, USA.
Klein
Allan L
AL
D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications / Q000628:therapy*; D002985:Clinical Protocols; D003131:Combined Modality Therapy; D003663:Decision Trees; D017548:Echocardiography, Transesophageal; D004554:Electric Countershock / Q000009:adverse effects / Q000379:methods*; D004617:Embolism / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D017063:Outcome Assessment, Health Care; D016032:Randomized Controlled Trials as Topic; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control; D013997:Time Factors; D014859:Warfarin / Q000627:therapeutic use*
D000925:Anticoagulants; D014859:Warfarin